Brilinta Tablets and Insulin Glargine (U-300) Pens
Determining the interaction of Brilinta Tablets and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ticagrelor
Brand name: Brilinta
Synonyms: Brilinta
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brilinta Tablets-Insulin glargine and lixisenatide
- Brilinta Tablets-Insulin glargine and lixisenatide Subcutaneous
- Brilinta Tablets-Insulin glargine, recombinant Subcutaneous
- Brilinta Tablets-Insulin glulisine
- Brilinta Tablets-Insulin Glulisine (Cartridges and Pens)
- Brilinta Tablets-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Brimonidine
- Insulin Glargine (U-300) Pens-Brimonidine and brinzolamide ophthalmic
- Insulin Glargine (U-300) Pens-Brimonidine and Timolol
- Insulin Glargine (U-300) Pens-Brimonidine and timolol ophthalmic
- Insulin Glargine (U-300) Pens-Brimonidine ophthalmic
- Insulin Glargine (U-300) Pens-Brimonidine Tartrate eent